Browsing Tag
Pharmexcil
Pharmexcil upbeat on export growth prospects in South Korea, inks MoU with KPBMA
South Korea with its focus on providing universal health coverage, for the people, and emphasis on cost containment measures is poised to emerge as a growth market for generic medicines from India, according to the Pharmaceuticals Export…
Pharmexcil suspends Marion Biotech membership
The alleged supply of substandard medicines by the company has been linked to the deaths of children in Uzbekistan.
| Photo Credit: REUTERS
Pharmaceuticals Export Promotion Council of India has suspended from its membership Marion Biotech,…
Pharma industry to grow to $130 billion by 2030: Pharmexcil
The Indian pharmaceutical industry is expected to grow at a compound annual rate (CAGR) of 12% and reach $130 billion by 2030, industry executives said at an industry event.“There is a strong push from the government towards creating an…
Indian pharma exports rise by 4.22% to $14.57 billion during April-Oct in current fiscal –…
HYDERABAD: Pharmaceutical exportsfrom India registered a growth of 4.22% to reach $14.57 billion during the April-October period despite a negative trend last month, according to a senior official of an export promotion body under…
Nigeria accuses Indian drug makers, exporters of unethical practices
Accusing Indian pharmaceutical manufacturers and exporters of indulging in unethical and unprofessional practices in connivance with Nigerian importers, Nigeria’s drug regulator NAFDAC has warned them of stringent action.In an alert to…
Now, Russia seeks veterinary medicines
Several Russian companies have approached the Pharmaceuticals Export Promotion Council of India (Pharmexcil) to secure urgent supplies of veterinary medicines as sanctions imposed by the West have led to shortages of medicines…
DCGI extends drug imports deadline on shelf-life rule
With the existing deadline till October 31, the latest extension is for six months
The Drugs Controller General of India (DCGI) has extended till April 30 the deadline for allowing import of drugs with residual shelf life less than…